Specific and non-specific neurological symptoms have been reported in patients with COVID-19 [1, 2] and different studies documented an increase of NfL levels during the acute phase of the infection, thus supporting the occurrence of concomitant acute axonal damage [4, 5, 7, 8]. The gene discussed is NEFL; the disease is infection.